Composite Lymphoma
Showing 1 - 25 of 6,823
Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular
Recruiting
- Aggressive B-Cell Non-Hodgkin Lymphoma
- +19 more
- CD47 Antagonist ALX148
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2022
Composite Lymphoma, Grade 3b Follicular Lymphoma, Stage I DLBCL Trial in Seattle (drug, other, biological)
Completed
- Composite Lymphoma
- +9 more
- Cyclophosphamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 22, 2020
Lymphoma Trial (Fatigue Reduction Diet, General Health Curriculum)
Not yet recruiting
- Lymphoma
- Fatigue Reduction Diet
- General Health Curriculum
- (no location specified)
Sep 14, 2023
Leukemia, Lymphoma, Myeloma Trial in Miami, Chicago, San Antonio (LLS Program)
Not yet recruiting
- Leukemia
- +4 more
- LLS Program
-
Miami, Florida
- +2 more
Feb 16, 2023
Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell
Not yet recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- +5 more
- Pembrolizumab
- +3 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2023
T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)
Active, not recruiting
- T-Cell Lymphoma
- +4 more
- LB1901
-
Rochester, Minnesota
- +3 more
Feb 15, 2022
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +8 more
- Cyclophosphamide
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 30, 2022
Cutaneous T-Cell Lymphoma Trial in United States (SGX301 (synthetic hypericin), Placebo)
Completed
- Cutaneous T-Cell Lymphoma
- SGX301 (synthetic hypericin)
- Placebo
-
Birmingham, Alabama
- +32 more
Mar 22, 2022
Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,
Not yet recruiting
- Mycosis Fungoides of Skin (Diagnosis)
- +5 more
- Med-Jet Injector
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)
Terminated
- T-Acute Lymphoblastic Leukemia
- Adult T Lymphoblastic Lymphoma
-
Saint Louis, Missouri
- +1 more
Jan 18, 2023
Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)
Not yet recruiting
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides
- Hypericin
- Mechlorethamine Topical Gel
-
Fairport, New YorkRochester Skin Lymphoma Medical Group
Nov 20, 2023
Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States
Terminated
- Acute Myeloid Leukemia
- +2 more
- Venetoclax
- AMG 176
-
Duarte, California
- +16 more
Dec 3, 2021
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in
Completed
- Hodgkin's Disease
-
Louisville, KentuckyNorton Cancer Institute
Dec 14, 2021
Prevention & Control Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin )
Completed
- Prevention & Control
- Rivaroxaban (Xarelto, BAY59-7939)
- +5 more
-
Birmingham, Alabama
- +564 more
Nov 3, 2022
Defective Composite Restorations Trial in Irbid (composite restoration repair by traditional acid etch treatment procedure and
Active, not recruiting
- Defective Composite Restorations
- composite restoration repair by traditional acid etch treatment procedure and adhesive.
- +2 more
-
Irbid, JordanJordan University of Science and Technology
Aug 21, 2023
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- Hypericin
- Visible Light
- (no location specified)
May 23, 2023
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Dasatinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 20, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Ruxolitinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 16, 2023
Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,
Recruiting
- Childhood Non-Hodgkin Lymphoma
- +2 more
- Goal Management Training (GMT)
- Brain Health Workshop (BHW)
-
Oslo, Norway
- +2 more
May 25, 2022
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Decitabine
- +3 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 22, 2023
Dental Caries Trial in Cairo (complex proximal carious cavities in posterior teeth.)
Recruiting
- Dental Caries
- complex proximal carious cavities in posterior teeth.
-
Cairo, Nasr City, EgyptMohamed Mohamed sabry Mohamed
Aug 26, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Trametinib
- +4 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Dec 13, 2022
Clinical Performance Trial (NovaProTM Fill Universal Dental Composite)
Not yet recruiting
- Clinical Performance
- NovaProTM Fill Universal Dental Composite
- (no location specified)
Mar 29, 2023
Clinical Performance Trial (Injectable resin composite technique., Conventional layering technique)
Not yet recruiting
- Clinical Performance
- Injectable resin composite technique.
- Conventional layering technique
- (no location specified)
Jul 12, 2023